Chemotherapy Resistance in Lung Cancer.

Chemotherapy Resistance in Lung Cancer.

Item
http://www.wikidata.org/entity/Q38669287
Up-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin J.Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity.Spatial distribution of EGFR and KRAS mutation frequencies correlates with histological growth patterns of lung adenocarcinomas.Extracellular signal-regulated kinase 8-mediated NF-κB activation increases sensitivity of human lung cancer cells to arsenic trioxide.Comparative Network Analysis of Patients with Non-Small Cell Lung Cancer and Smokers for Representing Potential Therapeutic Targets.MALAT1-miR-101-SOX9 feedback loop modulates the chemo-resistance of lung cancer cell to DDP via Wnt signaling pathway.p53 loss does not permit escape from BrafV600E-induced senescence in a mouse model of lung cancer.Trps1 is associated with the multidrug resistance of lung cancer cell by regulating MGMT gene expression.Importance of the Keap1-Nrf2 pathway in NSCLC: Is it a possible biomarker?FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC
P2860

Chemotherapy Resistance in Lung Cancer.

Item
http://www.wikidata.org/entity/Q38669287
description
2016 nî lūn-bûn
@nan
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
name
Chemotherapy Resistance in Lung Cancer.
@en
type
label
Chemotherapy Resistance in Lung Cancer.
@en
prefLabel
Chemotherapy Resistance in Lung Cancer.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P577
P698
P921
P356
P1433
P1476
Chemotherapy Resistance in Lung Cancer.
@en
P2093
P2860
P304
P31
P356
10.1007/978-3-319-24223-1_10
P407
P478
P577
P698
P921